Condition: Schizophrenia Prodromal · Schizophrenia, Childhood · Schizophrenia · Sponsor: University Hospital, Brest
Establishment of a patient library for patients who have had a first psychotic episode and who have an "at risk" status for psychotic disorder (GRD, APS, BLIPS group) or a psychosis threshold during CAARMS administration. Samples are taken on inclusion, at 2 years, and if relapse or significant clinical event within 5 years of inclusion, on 250 patients for 10 years.
This description comes directly from the study's public registry record.
Michel WALTER · +332 98 01 51 56 · michel.walter@chu-brest.fr
Christophe LEMEY · +336 19 21 10 32 · christophe.lemey@chu-brest.fr
Always discuss trial participation with your own doctor first.
| Chu Brest | Brest, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05340348